Constellation Software, Allscripts History & Post-Acquisition Strategy
Former Allscripts / Altera Senior Executive
inpractise.com/articles/constellation-software-allscripts-history-and-post-acquisition-strategy
Former Allscripts / Altera Senior Executive
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Why was Allscripts struggling, in the years leading up to the divestiture? Revenue was consistently down around 5% a year.
They were losing clients, having a hard time retaining clients, and being pushed into smaller markets. Instead of being in large health systems and academic centers, we were pushed down into community hospitals with 50 to 90 beds because we had lost footing in the larger ones, which were all going to Cerner or Epic.
This is a snippet of the transcript, sign up to read more.
What happens if a hospital doesn't implement these meaningful use upgrades or comply with them?
Initially, hospitals were incentivized with meaningful use money. Later, reimbursement penalties were introduced for hospitals that were not digitally mature. Some smaller, critical access hospitals were not affected, but in general, there was an expectation from Washington that hospitals would become digitally mature and be able to transact certain information to patients, such as visit summaries and discharge information.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.